Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
    • COVID-19
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • CHEST 2021
    • IDWeek 2021
    • IAS 2021
    • ADA 2021
    • ATS 2021
    • ACC 2021
    • ACP 2021
    • AAN 2021
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
    • COVID-19
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • CHEST 2021
    • IDWeek 2021
    • IAS 2021
    • ADA 2021
    • ATS 2021
    • ACC 2021
    • ACP 2021
    • AAN 2021

More articles from Plenary Session Abstract

  • You have access
    Sequential Epitope Mapping of the Myeloperoxidase Antigen
    DM Wynn, and JA James,
    Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-60;
  • You have access
    Henoch-Schönlein Purpura and Cutaneous Leukocy-Toclastic Angiitis Exhibit Different HLA-DRB1 Associations
    MM Amoli,, W Thomson,, AH Hajeer,, MC Calviño,, C Garcia-Porrua,, WER Ollier, and MA Gonzalez-Gay,
    Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-90;
  • You have access
    Randomized Trial of Cyclophosphamide Versus Methotrexate for Induction of Remission in “Non-Renal” Anca-Associated Vasculitis
    K de Groot,, N Rasmussen,, JW Cohen Tervaert,, DRW Jayne, and ,
    Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-116;
  • You have access
    Ethnic Disparity in the Incidence of Temporal Arteri-Tis: a 32-Year Experience at an Urban Medical Center
    MJ Regan,, WR Green, and JH Stone,
    Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-83;
  • You have access
    Novel Effects of Inflammatory Cell Proteases on Vascular Endothelia
    GA Preston,, WF Pendergraft,, JJ Yang,, JC Jennette, and RJ Falk,
    Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-50;
  • You have access
    Campath 1-H (Anti-CD52) for Refractory Vasculitis: Retrospective Cambridge Experience 1989–1999
    DRW Jayne,
    Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-129;
  • You have access
    HMG-CoA Reductase Inhibitors Decrease Anca-Mediated Activation Of Human Neutrophils
    M Choi,, S Rolle,, M Rane,, H Haller,, FC Luft, and R Kettritz,
    Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-68;

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2022 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire